McGill researchers awarded Cancer Research Society Funding
New grants will support projects spanning tumour biology, immunotherapy and breast and lung cancer research.
For members of sexual and gender minorities, trauma therapies work best when adapted to their realities, study suggests
When therapies for psychological trauma are adapted for sexual and gender minorities and delivered by therapists with high levels of sensitivity to their experiences, outcomes are better, according to a scoping review by McGill University researchers. In particular, there are fewer post-traumatic stress symptoms such as nightmares and intrusive thoughts, as well as risk-taking behaviours (e.g., self-harm, drug use), the researchers said.
The brain’s ‘dimmer switch’ could help explain why attention drifts
McGill researchers have discovered that serotonin, a brain chemical best known for its role in mood and mental health, also helps regulate attention.
Research | Building the Foundation for Personalized RNA Therapeutics in Heart Disease
McGill researchers have developed a new way to study why the same heart-failure treatment can help some patients recover while others continue to worsen. The research was co-led by Diego Loggia, a D2R Scholar and PhD student in McGill's Department of Pharmacology & Therapeutics.
Nineteen Canada Research Chairs awarded to McGill
Funding backs innovative research in an array of disciplines, including health sciences, music and social work.
The Government of Canada has awarded McGill $19 million in funding to support 19 researchers through the Canada Research Chairs (CRC) Program – 11 new and eight renewed appointments.
Prix du Québec honours for Nathalie Tufenkji
McGill environmental engineer who focuses on ‘problems that matter outside the lab’ recognized for research on plastic pollution By Neale McDevitt
'Heart-in-a-dish' paves way for personalized treatment for heart failure
McGill researchers have developed a new way to study why the same heart-failure treatment can help some patients recover while others continue to get worse.
Combining “heart-in-a-dish” technology with advanced microscopy, the approach makes it possible to identify differences between patients that would probably be missed using conventional methods.
Day in the Lab: Inspiring Girls Through Science
Last week, D2R accompanied high school girls in Grades 7-9 from Les Scientifines on a visit to the Biomedical Engineering Lab of D2R-funded researcher Caroline Wagner at McGill University. The visit offered students a firsthand look at the exciting world of science.
McGill Hearing Screening
No appointment needed.
First come, first serve.
Thank you
Lawrence Kazak awarded NSERC’s Arthur B. McDonald Fellowship
McGill researcher at the forefront of metabolic science recognized with $250,000 award for promising early-career scientists
New treatment approach shows promise in reducing prostate cancer spread
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international Phase 3 trial.
New approach aims to make personalized RNA therapies accessible to more children with rare genetic brain disorders
Montreal, October 23, 2026 – For families of children with rare genetic neurodevelopmental disorders, receiving a diagnosis can provide an explanation for their child’s condition, but often offers few treatment options.
Researchers at McGill University are working to change that.
Several schizophrenia symptoms linked to a single brain signal
A single brain signal may help explain a range of seemingly unrelated schizophrenia symptoms, a new study has found.
Schizophrenia is often described as a list of separate problems. People may perceive the world differently, act on their surroundings differently, or speak in ways that are hard to follow.
Discovery could help predict which early breast cancers will spread
Immune cells that normally protect the body from infection can also drive the progression of some early breast cancers, McGill University researchers have found.
The discovery points to a potential way of distinguishing relatively harmless cases of ductal carcinoma in situ (DCIS) from those most likely to become invasive, one of the biggest challenges in breast cancer care.
What makes us human? A first atlas of functional DNA changes offers new clues
A new genetic atlas is helping scientists trace the DNA changes that transformed a shared primate ancestor into modern humans.
For the first time, researchers can systematically test which genetic differences between humans and chimpanzees affect gene activity.
